Challenges to heart failure medication prescribing post-hospitalization.
Int J Pharm Pract
; 2024 Jul 15.
Article
en En
| MEDLINE
| ID: mdl-39011608
ABSTRACT
OBJECTIVES:
To determine the prevalence of heart failure (HF) medication prescribing on discharge post-HF-related admission.METHODS:
A retrospective audit was conducted for 216 HF admissions over a period of 6 months; medication data from electronic records were collected for analysis. KEYFINDINGS:
The prevalence of HF medication prescribing on discharge was 32.9% (95% confidence interval 26.6-39.6) renin-angiotensin-aldosterone system inhibitors, 10.6% (6.9-15.6) angiotensin receptor-neprilysin inhibitors, 31.5% (25.4-38.1) HF-specific beta-blockers, 42.6% (35.9-49.5) aldosterone receptor antagonists, and 11.6% (7.6-16.6) sodium-glucose cotransporter-2 inhibitors.CONCLUSION:
HF medication prescribing remains relatively low despite the known benefits and recommendations listed in the guidelines.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Int J Pharm Pract
Asunto de la revista:
FARMACIA
Año:
2024
Tipo del documento:
Article